Floatz logo

Semaglutide

Osteoarthritis (OA) of the Knee

The University of Hong Kongprotein_peptideEarly Phase 1Active
C
39/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
24/ 100
Competitive Position
89/ 100

Competitive context

3 Active assets in the Osteoarthritis (OA) of the Knee cohort.

Asset / SponsorPhaseRating
Letrozole
The University of Hong Kong
Early Phase 1C
Metformin
The University of Hong Kong
Early Phase 1C
TRIAMCINOLONE ACETONIDE 21-ACETATE
Brixton Biosciences, Inc.
N/AD

Same molecule, other indications

Semaglutide is also rated in:

metabolic diseaseDormant
A
Indicative ·
81 / 100
View asset →
type 2 diabetes mellitusDormant
BBB
Indicative ·
79 / 100
View asset →
polycystic ovary syndromeDormant
BBB
Indicative ·
79 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →